Updated on 14 July 2014
Sinopharm is jointly owned by China National Pharmaceutical Group and Shanghai Fosun Pharmaceutical. Directly controlled by the state-owned Assets Supervision and Administration Commission of the State Council, it is recognized as China's largest and only nationwide distributor and wholesaler.
"The largest medical and healthcare group in China grew to $25.8 billion last year, registering a 25 percent growth."
The reforms in the healthcare sector over the last three years have changed the face of this company. They found a market that is advancing and is easy to penetrate and dominate - thanks to Sinopharm's strong and wide countrywide network.
Establishing a steady growth over the years, the company increased its market share and profits this year and its overall revenue grew from $21.73 in 2012-13 to $25.89 billion in 2013-14.